-
1Report
المصدر: Randomized, Double-Blinded Phase III Study of CABozantinib Versus Placebo IN Patients With Advanced NEuroendocrine Tumors After Progression on Prior Therapy (CABINET)
Kunz PL. Angiogenesis inhibitors in neuroendocrine tumours: finally coming of age. Lancet Oncol. 2020 Nov;21(11):1395-1397. doi: 10.1016/S1470-2045(20)30560-X. No abstract available. -
2Report
المصدر: Prospective Randomized Phase II Trial of Pazopanib (NSC #737754) Versus Placebo in Patients With Progressive Carcinoid Tumors
-
3Report
المصدر: Evaluation of Dual Energy CT for the Detection of Gastrointestinal Carcinoids
-
4Report
المصدر: A Phase I Trial of the mTOR Inhibitor RAD001 in Combination With VEGF Receptor Tyrosine Kinase Inhibitor PTK787/ZK 222584 in Patients With Advanced Solid Tumors
-
5Report
المصدر: An Observational Study to Evaluate the Real-world Experience of Patients Who Are Initiating Treatment With Telotristat Ethyl (XERMELO™)
Li D, Darden C, Osman N, Sayeed S, Jackson L, Garbinsky D, Chauhan A. Real-World Clinical and Patient-Reported Outcomes from the Longitudinal Telotristat Ethyl Treatment Registry of Patients with Neuroendocrine Tumors. Cancer Manag Res. 2022 Oct 17;14:3009-3020. doi: 10.2147/CMAR.S386419. eCollection 2022. -
6Report
المساهمون: Krithika Loganath, Principal Investigator
المصدر: Fibrosis in Chronic and Delayed Myocardial Infarction
-
7Report
المؤلفون: Royal Free Hospital NHS Foundation Trust
المصدر: Single Centre, Prospective, Single Arm Open Label Series of a Transcatheter Tricuspid Valved Stent Graft System for the Reduction of Tricuspid Regurgitation and Improved Patient Reported Outcomes in Patients With Carcinoid Heart Disease
-
8Academic Journal
المؤلفون: Marasco, Matteo, Romano, Elena, Arrivi, Giulia, Prosperi, Daniela, Rinzivillo, Maria, Caruso, Damiano, Mercantini, Paolo, Rossi, Michele, Faggiano, Antongiulio, Panzuto, Francesco
المصدر: Cancers; Nov2024, Vol. 16 Issue 22, p3831, 17p
-
9Academic Journal
المصدر: World Journal of Laparoscopic Surgery; Sep-Dec2024, Vol. 17 Issue 3, p149-152, 4p
مصطلحات موضوعية: COMPARATIVE studies, LAPAROSCOPY, NEPHRECTOMY, HOSPITAL administration, MALIGNANT carcinoid syndrome
-
10Report
المصدر: A Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects With Carcinoid Syndrome
-
11Report
المؤلفون: National Cancer Institute (NCI)
المصدر: A Phase II Clinical and Biologic Study of AMG 706 and Octreotide in Patients With Low-Grade Neuroendocrine Tumors
Lubner S, Feng Y, Mulcahy M, O'Dwyer P, Giang GY, Hinshaw JL, Deming D, Klein L, Teitelbaum U, Payne J, Engstrom P, Stella P, Meropol N, Benson A. E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors. Oncologist. 2018 Sep;23(9):1006-e104. doi: 10.1634/theoncologist.2018-0294. Epub 2018 May 31. -
12Report
المؤلفون: Genentech, Inc., Sanofi
المصدر: A Pilot Study of FOLFOX in Combination With Bevacizumab in Patients With Advanced Neuroendocrine Tumors
-
13Report
المؤلفون: National Cancer Institute (NCI)
المساهمون: Anthony F. Shields, MD PhD, Principal Investigator
المصدر: Monitoring Telotristat Ethyl Inhibition of Tryptophan Hydroxylase (TPH) in Neuroendocrine Tumors Using ?-[11C]Methyl-L-tryptophan (AMT)-PET
-
14Report
المساهمون: Chandrikha Chandrasekhara, Clinical Assistant Professor of Internal Medicine - Hematology, Oncology and Blood and Marrow Transplantation
المصدر: Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl (NET-PACS Trial) Big Ten Cancer Research Consortium BTCRC-GI19-400
-
15Report
المؤلفون: Entrinsic Bioscience Inc.
المساهمون: Lowell Anthony, MD, Principal Investigator
المصدر: A Phase 2 Study Evaluating a Proprietary Amino Acid Based Medical Food (Enterade®) in Patients With Quality of Life Limiting Diarrhea Due to Carcinoid Syndrome and Other Neuroendocrine Tumors (NET).
-
16Report
المصدر: A Double Blind, Randomized Placebo Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome
Vinik AI, Wolin EM, Liyanage N, Gomez-Panzani E, Fisher GA; ELECT Study Group *. EVALUATION OF LANREOTIDE DEPOT/AUTOGEL EFFICACY AND SAFETY AS A CARCINOID SYNDROME TREATMENT (ELECT): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Endocr Pract. 2016 Sep;22(9):1068-80. doi: 10.4158/EP151172.OR. Epub 2016 May 23.
Blot K, Duchateau L, Lescrauwaet B, Liyanage N, Ray D, Mirakhur B, Vinik AI. A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial. Patient Relat Outcome Meas. 2019 Oct 29;10:335-343. doi: 10.2147/PROM.S219982. eCollection 2019.Other URLs: https://vivli.org/members/ourmembers/
-
17Academic Journal
المؤلفون: Cali, Nikki A., Falat, Cheyenne, Bontempo, Laura J., Gatz, J. David
المصدر: Clinical Practice and Cases in Emergency Medicine. 6(3)
مصطلحات موضوعية: emergency medicine, clinicopathological conference, case reports, edema, carcinoid tumor, malignant carcinoid syndrome, carcinoid heart disease
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/8256p81k
-
18Academic Journal
المؤلفون: Abdalla, Hesham, Nkomo, Vuyisile, Arsanjani, Reza, Alsidawi, Said
المصدر: European Heart Journal - Cardiovascular Imaging; Jan2025, Vol. 26 Issue 1, p148-149, 2p
مصطلحات موضوعية: TRICUSPID valve surgery, PROSTHETICS, MITRAL valve surgery, PULMONARY edema, ARTIFICIAL implants, MITRAL valve insufficiency, SURGICAL complications, MALIGNANT carcinoid syndrome, DYSPNEA, POSTOPERATIVE period, TRICUSPID valve diseases, ECHOCARDIOGRAPHY, DISEASE risk factors, DISEASE complications
-
19Academic Journal
المؤلفون: Anthony, Lowell B, Kulke, Matthew H, Caplin, Martyn E, Bergsland, Emily, Öberg, Kjell, Pavel, Marianne, Hörsch, Dieter, Warner, Richard RP, O'Dorisio, Thomas M, Dillon, Joseph S, Lapuerta, Pablo, Kassler‐Taub, Kenneth, Jiang, Wenjun
المصدر: The Oncologist. 24(8)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Clinical Research, Neurosciences, Patient Safety, Digestive Diseases, Clinical Trials and Supportive Activities, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Diarrhea, Female, Humans, Male, Malignant Carcinoid Syndrome, Middle Aged, Phenylalanine, Pyrimidines, Randomized Controlled Trials as Topic, Retrospective Studies, Treatment Outcome, Malignant carcinoid syndrome, Tryptophan hydroxylase, Telotristat ethyl, Serotonin, Neuroendocrine tumors, Oncology and Carcinogenesis, Oncology & Carcinogenesis, Oncology and carcinogenesis
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/57x9g9tv
-
20Report
المؤلفون: National Cancer Institute (NCI)
المصدر: Phase II Study of Single Agent Regorafenib in Patients With Advanced/Metastatic Neuroendocrine Tumors